+39 02 610346.1 - info@newron.com

Latest press releases

  • 17Feb
    Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia


  • 4Feb
    Newron Pharmaceuticals to Present at the 22nd Annual BIO CEO & Investor Conference in New York

  • 9Jan
    Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA


  • 9Dec
    Newron Pharmaceuticals to Request Type A FDA Meeting Prior to Unblinding of STARS Clinical Trial Data


  • 25Nov
    Newron Receives Second Tranche from Financing Agreement with European Investment Bank (EIB)


  • 19Nov
    Newron Receives FDA Rare Pediatric Disease Designation for Sarizotan for the Treatment of Rett Syndrome


View All

Newron share price


  • 13Jan
    J.P. Morgan 38th Annual Healthcare Conference 2020

    January 13-16, 2020 - San Francisco, CA, USA

  • 16Jan
    Baader Helvea Swiss Equities Conference

    January 16-17, 2020 - Bad Ragaz – Switzerland

  • 10Feb
    BIO CEO & Investor Conference 2020

    February 10-11, 2020 - New York, NY, USA

View Event Calendar